Healthcare -
Biotechnology - NASDAQ - US
$ 493.756
-0.384 %
$ 52.4 B
Market Cap
12.27
P/E
REGN - TOTAL ASSETS
Total Assets REGN - Regeneron Pharmaceuticals, Inc.
37.8 B
LAST VALUE
13.69%
2 YEAR CAGR
20.59%
5 YEAR CAGR
25.58%
10 YEAR CAGR